Betting and Winning: SCOTUS Decision Underscores High Stakes In Pharma’s Strategy
This article was originally published in RPM Report
Executive Summary
The Supreme Court decision was a decisive victory for the biopharma industry for a number of reasons. But the drama that unfolded in a razor-close decision will continue as new milestones—political and legislative—approach.